Company Dx & Vx Co., Ltd.

Equities

A180400

KR7180400004

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Diagnostics & Testing

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
4,490 ^KRW	-0.44%		-2.81%	-24.03%

2023	Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS	CI
2023	Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers	CI

Dx & Vx Co Ltd, formerly Cancer Rop Co Ltd, is a Korea-based company primarily engaged in the molecular diagnosis business. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.

KRW in Million	2022	Weight	2023	Weight	Delta
Healthcare 84.9 %	-	-	39,686	84.9 %	-
Medical Diagnosis 15.0 %	-	-	7,014	15.0 %	-
New Medicine 0.1 %	-	-	46	0.1 %	-

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 48.8 %	32,184	100.0 %	22,800	48.8 %	-29.16%
Other 34.6 %	-	-	16,171	34.6 %	-
China 16.6 %	-	-	7,774	16.6 %	-

Managers	Title	Age	Since
Lee Yong-Gu CEO	Chief Executive Officer	-	15/05/23
Gyu-Chan Kwon PSD	President	54	15/05/23
Gang-Pyeong Lee DFI	Director of Finance/CFO	55	-
Baek-Seung Lee CTO	Chief Tech/Sci/R&D Officer	54	-
Wang-Jun Lee CTO	Chief Tech/Sci/R&D Officer	59	12/12/17
Do-Soon Hwang BRD	Director/Board Member	61	-
Byeong-Gu Lee AUD	Comptroller/Controller/Auditor	51	-
Sang-Jin Park PRN	Corporate Officer/Principal	53	07/01/07

Members of the board	Title	Age	Since
Do-Soon Hwang BRD	Director/Board Member	61	-
Wang-Jun Lee CTO	Chief Tech/Sci/R&D Officer	59	12/12/17
Baek-Seung Lee CTO	Chief Tech/Sci/R&D Officer	54	-
Ji-Jun Song BRD	Director/Board Member	50	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	30,219,432	22,244,354 ( 73.61 %)	736 ( 0.002436 %)	73.61 %

Name	Equities	%	Valuation
Jong-Yoon Lim 19.25 %	5,816,189	19.25 %	19 M ₩
Wang-Jun Lee 4.671 %	1,411,643	4.671 %	5 M ₩
Platform Partners Asset Management Co., Ltd. 3.332 %	1,006,791	3.332 %	3 M ₩
MJ Bio Holdings Co. Ltd. 2.316 %	700,000	2.316 %	2 M ₩
Sang-Jin Park 0.3363 %	101,616	0.3363 %	324 236 ₩
Lee Yong-Gu 0.0599 %	18,100	0.0599 %	57 753 ₩
Gyu-Chan Kwon 0.0529 %	16,000	0.0529 %	51 053 ₩
Dx & Vx Co., Ltd. ESOA 0.0184 %	5,569	0.0184 %	17 770 ₩
DX & VX CO., LTD. 0.002436 %	736	0.002436 %	2 348 ₩
Jeong-min Kim 0.001324 %	400	0.001324 %	1 276 ₩

Name	Equities	%	Valuation
HANMI SCIENCE CO., LTD. 0.41%	288,999	0.41%	7,109,448 $
DX & VX CO., LTD. 0.00%	736	0.00%	2,348 $

Dx & Vx Co., Ltd.

Unit 1003, Elysia Building 173 Digital-ro

08511, Seoul

http://www.cancerrop.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
DX & VX CO., LTD.	-24.03%	99.44M
EXACT SCIENCES CORPORATION	-27.43%	9.96B
GUARDANT HEALTH, INC.	-7.47%	3.03B
IOVANCE BIOTHERAPEUTICS, INC.	+31.73%	3B
BGI GENOMICS CO., LTD.	-14.73%	2.18B
VERACYTE, INC.	-14.61%	1.76B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+66.87%	1.42B
CAREDX, INC	+23.33%	794M
SEEGENE, INC.	-2.18%	756M
CURIOX BIOSYSTEMS CO., LTD	+3.18%	305M

Bio Diagnostics & Testing